文献速递重症综合管理与镇静镇痛儿科与产科急症

PCSK9功能缺失通过独立影响Angiopoietin-1对儿童脓毒症宿主反应产生有害作用

Detrimental effects of PCSK9 loss-of-function in the pediatric host response to sepsis are mediated through independent influence on Angiopoietin-1.
PubMed 文献 · Crit Care · 2023-06-26
一句话结论儿童脓毒症休克中,PCSK9功能缺失基因型与Angpt-1降低相关,且Angpt-1介导了PCSK9功能缺失对死亡的影响。

该研究为前瞻性观察性队列的二次分析,纳入474例儿童脓毒症休克患者,检测PCSK9及LDLR基因变异、血清PCSK9、脂蛋白及第1天血清内皮功能障碍标志物。多变量线性回归显示,PCSK9功能缺失与Angpt-1浓度相关(校正混杂因素后,包含LDL的模型错误发现率校正P=0.042,包含HDL的模型P=0.013)。因果中介分析表明,PCSK9功能缺失对死亡的影响由Angpt-1介导(P=0.0008)。幼年Pcsk9敲除小鼠脓毒症模型中Angpt-1较低、可溶性血栓调节蛋白较高,与人类数据一致。作者认为PCSK9-LDLR通路可能直接影响发育期宿主Angpt-1,需外部验证。

要点

  • 在474例儿童脓毒症休克患者中,PCSK9功能缺失与Angpt-1浓度相关,校正LDL后错误发现率校正P=0.042,校正HDL后P=0.013。
  • 因果中介分析显示,PCSK9功能缺失对死亡的影响由Angpt-1介导(P=0.0008)。
  • 排除对PCSK9不敏感的rs688 LDLR变异纯合子后,PCSK9功能缺失与内皮功能障碍标志物的关联增强。
  • 幼年Pcsk9敲除小鼠脓毒症模型中,Angpt-1较低、可溶性血栓调节蛋白较高,与野生型相比。
  • 血清PCSK9与内皮功能障碍无相关性。

适用人群与场景

  • 儿童脓毒症休克患者,来自前瞻性观察性队列,共474例。
  • 幼年Pcsk9敲除与野生型小鼠,接受盲肠浆液脓毒症模型。

研究设计与关键结果

  • 研究类型:前瞻性观察性队列的二次分析,纳入474例儿童脓毒症休克患者。
  • PCSK9功能缺失与多种内皮功能障碍标志物相关,排除rs688 LDLR变异纯合子后关联增强。
  • 血清PCSK9与内皮功能障碍无相关性。
  • PCSK9功能缺失影响Angpt-1浓度,校正包括脂蛋白在内的潜在混杂因素后,包含LDL的模型错误发现率校正P=0.042,包含HDL的模型P=0.013。
  • 因果中介分析显示,PCSK9功能缺失对死亡的影响由Angpt-1介导(P=0.0008)。
  • 小鼠数据与人类结果一致:脓毒症敲除小鼠较野生型Angpt-1较低、可溶性血栓调节蛋白较高。

证据类型、等级与局限

  • 证据类型:前瞻性观察性队列的二次分析及小鼠实验。
  • 局限:作者指出需外部验证(warrant external validation)。

对床旁实践的改变

  • 作者认为,PCSK9-LDLR通路可能直接影响发育期宿主脓毒症休克中的Angpt-1,需外部验证。
  • 作者认为,进一步研究PCSK9-LDLR通路对血管稳态的作用可能促进儿童特异性脓毒症疗法的开发。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Sepsis is associated with significant mortality. Yet, there are no efficacious therapies beyond antibiotics. PCSK9 loss-of-function (LOF) and inhibition, through enhanced low-density lipoprotein receptor (LDLR) mediated endotoxin clearance, holds promise as a potential therapeutic approach among adults. In contrast, we have previously demonstrated higher mortality in the juvenile host. Given the potential pleiotropic effects of PCSK9 on the endothelium, beyond canonical effects on serum lipoproteins, both of which may influence sepsis outcomes, we sought to test the influence of PCSK9 LOF genotype on endothelial dysfunction.

METHODS: Secondary analyses of a prospective observational cohort of pediatric septic shock. Genetic variants of PCSK9 and LDLR genes, serum PCSK9, and lipoprotein concentrations were determined previously. Endothelial dysfunction markers were measured in day 1 serum. We conducted multivariable linear regression to test the influence of PCSK9 LOF genotype on endothelial markers, adjusted for age, complicated course, and low- and high-density lipoproteins (LDL and HDL). Causal mediation analyses to test impact of select endothelial markers on the association between PCSK9 LOF genotype and mortality. Juvenile Pcsk9 null and wildtype mice were subject to cecal slurry sepsis and endothelial markers were quantified.

RESULTS: A total of 474 patients were included. PCSK9 LOF was associated with several markers of endothelial dysfunction, with strengthening of associations after exclusion of those homozygous for the rs688 LDLR variant that renders it insensitive to PCSK9. Serum PCSK9 was not correlated with endothelial dysfunction. PCSK9 LOF influenced concentrations of Angiopoietin-1 (Angpt-1) upon adjusting for potential confounders including lipoprotein concentrations, with false discovery adjusted p value of 0.042 and 0.013 for models that included LDL and HDL, respectively. Causal mediation analysis demonstrated that the effect of PCSK9 LOF on mortality was mediated by Angpt-1 (p = 0.0008). Murine data corroborated these results with lower Angpt-1 and higher soluble thrombomodulin among knockout mice with sepsis relative to the wildtype.

CONCLUSIONS: We present genetic and biomarker association data that suggest a potential direct role of the PCSK9-LDLR pathway on Angpt-1 in the developing host with septic shock and warrant external validation. Further, mechanistic studies on the role of PCSK9-LDLR pathway on vascular homeostasis may lead to the development of pediatric-specific sepsis therapies.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Atreya MR, Cvijanovich NZ, Fitzgerald JC, et al. Detrimental effects of PCSK9 loss-of-function in the pediatric host response to sepsis are mediated through independent influence on Angiopoietin-1. Crit Care. 2023. PMID: 37365661. doi:10.1186/s13054-023-04535-1

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。